Ignite Creation Date:
2025-12-24 @ 11:10 PM
Ignite Modification Date:
2026-05-12 @ 5:55 PM
Study NCT ID:
NCT06762769
Status:
RECRUITING
Last Update Posted:
2025-08-01
First Post:
2024-12-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma
Sponsor:
University College, London
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UCL/153707
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None